Efficacy, safety, and adherence of tocilizumab therapy in elderly patients with rheumatoid arthritis: A real-world observational study
Objective: We evaluated the efficacy, safety, and drug survival rate of tocilizumab in the elderly patients with rheumatoid arthritis (RA). Methods: This study was conducted in 108 RA patients who started tocilizumab between 2008 and 2018. The patients were divided into a young group (<65 years)...
Saved in:
Main Authors: | Yoshinobu Nakao, Yu Funakubo Asanuma, Takuma Tsuzuki Wada, Mayumi Matsuda, Hiroaki Yazawa, Yoshihiro Yoshida, Akira Todoriki, Ayumi Shintani, Toshihide Mimura |
---|---|
Format: | article |
Language: | EN |
Published: |
SAGE Publishing
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/40bf5bde4d984b6b9bd4dfa2440ba935 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of tocilizumab in the treatment of rheumatoid arthritis
by: Yasuaki Okuda
Published: (2008) -
Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
by: Mahamid M, et al.
Published: (2011) -
Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.
by: Sho Mokuda, et al.
Published: (2013) -
Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis
by: Sato T, et al.
Published: (2014) -
Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
by: Tanaka T, et al.
Published: (2014)